NEU 0.92% $19.32 neuren pharmaceuticals limited

Bell Potter lifts target to A$4.40/Share Vs A$3.75, page-27

  1. 295 Posts.
    lightbulb Created with Sketch. 16
    Time for a progress report. Hard to imagine that Torreya are NOT fielding some competition for R.O.W. with Acadia carrying the costs and expertise in presenting Trofinitide in phase 3. Seems like a free kick for some one. Like to know how enrolments are going there. Also progress on 2591.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.